Cargando…
A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849326/ https://www.ncbi.nlm.nih.gov/pubmed/35186252 http://dx.doi.org/10.1093/jscr/rjac018 |
_version_ | 1784652440427036672 |
---|---|
author | Hall, Catherine McLaren, Mairi Mosse, Charles |
author_facet | Hall, Catherine McLaren, Mairi Mosse, Charles |
author_sort | Hall, Catherine |
collection | PubMed |
description | Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseudotumours. An 83-year-old woman presented with severe obstructive jaundice, weight loss and an extreme elevation of CA 19–9 level of 3295 kU/L. Magnetic resonance cholangiopancreatography (MRCP) revealed a pancreatic mass amputating the biliary tree. Liver function tests revealed a cholestatic pattern and severe hyperbilirubinaemia (289umol/L). IgG4 level was found to be high at 7.97 g/L. After treatment with high-dose corticosteroids, repeat MRCP 2 months later revealed disappearance of the pancreatic mass. There was also normalization of the bilirubin and a dramatic decrease of CA 19–9. This case reports the highest published benign elevation of Ca19.9 level in the setting of IgG4 disease. Differentiation between cholangiocarcinoma and IgG4-RD is important, as the treatment is vastly different. |
format | Online Article Text |
id | pubmed-8849326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88493262022-02-17 A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma Hall, Catherine McLaren, Mairi Mosse, Charles J Surg Case Rep Case Report Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseudotumours. An 83-year-old woman presented with severe obstructive jaundice, weight loss and an extreme elevation of CA 19–9 level of 3295 kU/L. Magnetic resonance cholangiopancreatography (MRCP) revealed a pancreatic mass amputating the biliary tree. Liver function tests revealed a cholestatic pattern and severe hyperbilirubinaemia (289umol/L). IgG4 level was found to be high at 7.97 g/L. After treatment with high-dose corticosteroids, repeat MRCP 2 months later revealed disappearance of the pancreatic mass. There was also normalization of the bilirubin and a dramatic decrease of CA 19–9. This case reports the highest published benign elevation of Ca19.9 level in the setting of IgG4 disease. Differentiation between cholangiocarcinoma and IgG4-RD is important, as the treatment is vastly different. Oxford University Press 2022-02-16 /pmc/articles/PMC8849326/ /pubmed/35186252 http://dx.doi.org/10.1093/jscr/rjac018 Text en Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Hall, Catherine McLaren, Mairi Mosse, Charles A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title | A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title_full | A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title_fullStr | A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title_full_unstemmed | A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title_short | A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma |
title_sort | pancreatic mass and extreme elevation of ca 19–9: a benign masquerade of cholangiocarcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849326/ https://www.ncbi.nlm.nih.gov/pubmed/35186252 http://dx.doi.org/10.1093/jscr/rjac018 |
work_keys_str_mv | AT hallcatherine apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma AT mclarenmairi apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma AT mossecharles apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma AT hallcatherine pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma AT mclarenmairi pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma AT mossecharles pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma |